Loading...
Loading...
Browse all stories on DeepNewz
VisitNovo Nordisk Secures Land in Odense, Denmark for New Production Plant
Jul 23, 2024, 09:15 AM
Novo Nordisk, the maker of Ozempic and Wegovy, has secured land and planning permissions for a potential new production plant in Denmark. The site is located in Odense, Denmark's third-largest city, and preparatory excavation works have already begun. This move, announced on Tuesday, is part of Novo Nordisk's strategy to expand its production capabilities in response to the growing demand for its weight-loss drugs.
View original story
Markets
No • 50%
Yes • 50%
Official announcement from Novo Nordisk or credible news sources
No • 50%
Yes • 50%
Official announcement from Novo Nordisk or credible news sources
Yes • 50%
No • 50%
Official announcement from Novo Nordisk or credible news sources
New cardiovascular drug • 25%
New weight-loss drug • 25%
Other • 25%
New diabetes drug • 25%
Official announcement from Novo Nordisk or credible news sources
No approval • 25%
Both EMA and FDA approval • 25%
EMA approval • 25%
FDA approval • 25%
Official announcement from Novo Nordisk or credible news sources
More than 100,000 units per month • 25%
Less than 10,000 units per month • 25%
10,000 to 50,000 units per month • 25%
50,001 to 100,000 units per month • 25%
Official announcement from Novo Nordisk or credible news sources